Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
3 clinical trials · Condition
◉ Watch Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation (NCT06662058) | Emory University | 2025-08-25 |
| Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma (NCT06580054) | University of Michigan Rogel Cancer Center | 2025-03-05 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091) | National Cancer Institute (NCI) | 2022-07-06 |
| Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery (NCT03565783) | M.D. Anderson Cancer Center | 2018-07-03 |
Track Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.